1. Home
  2. JDZG vs PHGE Comparison

JDZG vs PHGE Comparison

Compare JDZG & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JDZG

JIADE LIMITED

HOLD

Current Price

$1.19

Market Cap

7.6M

Sector

Real Estate

ML Signal

HOLD

Logo BiomX Inc. COmmon Stock

PHGE

BiomX Inc. COmmon Stock

HOLD

Current Price

$0.68

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JDZG
PHGE
Founded
2020
2015
Country
China
United States
Employees
N/A
57
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
7.5M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
JDZG
PHGE
Price
$1.19
$0.68
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
539.6K
200.6K
Earning Date
04-10-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.25
52 Week High
$4.06
$8.50

Technical Indicators

Market Signals
Indicator
JDZG
PHGE
Relative Strength Index (RSI) 48.54 18.42
Support Level $1.14 $0.43
Resistance Level $2.26 $2.35
Average True Range (ATR) 0.17 0.28
MACD -0.05 -0.06
Stochastic Oscillator 9.92 0.83

Price Performance

Historical Comparison
JDZG
PHGE

About JDZG JIADE LIMITED

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: